These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7318145)

  • 41. Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.
    Alberts DS; Salmon SE; Chen HS; Moon TE; Young L; Surwit EA
    Cancer Chemother Pharmacol; 1981; 6(3):253-64. PubMed ID: 7318146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro characterization of the myelotoxicity of cyclopentenyl cytosine.
    Volpe DA; Du DL; Grieshaber CK; Murphy MJ
    Cancer Chemother Pharmacol; 1994; 34(2):103-8. PubMed ID: 8194161
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential and problems with growth of breast cancer in a human tumor cloning system.
    Von Hoff DD; Sandbach J; Osborne CK; Metelmann C; Clark GM; O'Brien M
    Breast Cancer Res Treat; 1981; 1(2):141-8. PubMed ID: 7348571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improved optical detection of colony enlargement and drug cytotoxicity in primary soft agar cultures of human solid tumour cells.
    Alley MC; Lieber MM
    Br J Cancer; 1984 Feb; 49(2):225-33. PubMed ID: 6199034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cytocidal activity and proliferative ability of macrophages infiltrating the EMT6 tumor.
    Stewart CC; Beetham KL
    Int J Cancer; 1978 Aug; 22(2):152-9. PubMed ID: 700887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. UICC Study Group on chemosensitivity testing of human tumors. Problems--applications--future prospects.
    Pihl A
    Int J Cancer; 1986 Jan; 37(1):1-5. PubMed ID: 3941017
    [No Abstract]   [Full Text] [Related]  

  • 47. Sensitization of pancreatic tumor xenografts to carmustine and temozolomide by inactivation of their O6-Methylguanine-DNA methyltransferase with O6-benzylguanine or O6-benzyl-2'-deoxyguanosine.
    Kokkinakis DM; Ahmed MM; Chendil D; Moschel RC; Pegg AE
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3801-7. PubMed ID: 14506174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro methods to complement in vivo approaches utilizing combinations of chemotherapy and immunotherapy.
    Sigel MM; Lichter W; Lopez DM
    Cancer Chemother Rep 2; 1974 Mar; 4(1):109-14. PubMed ID: 4133186
    [No Abstract]   [Full Text] [Related]  

  • 49. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
    Clutterbuck RD; Millar JL; McElwain TJ
    Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
    Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
    Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line.
    Floridi A; Gentile PF; Bruno T; Fanciulli M; Paggi MG; Zeuli M; Benassi M
    Anticancer Res; 1991; 11(2):789-92. PubMed ID: 1648334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of human metastatic clones by in vitro chemosensitivity testing. Implications for the clinical application of the clonogenic assay.
    Bertelsen CA; Korn EI; Morton DL; Kern DH
    Arch Surg; 1983 Dec; 118(12):1406-9. PubMed ID: 6651518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of an efficient method for culturing human mammary epithelial cells to study adriamycin sensitivity.
    Smith HS; Hackett AJ; Lan S; Stampfer MR
    Cancer Chemother Pharmacol; 1981; 6(3):237-44. PubMed ID: 7198517
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro assays of chemotherapeutic sensitivity.
    Carney DN; Winkler CF
    Important Adv Oncol; 1985; ():78-103. PubMed ID: 3916747
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor.
    Kuo YC; Liang CT
    Biomaterials; 2011 Apr; 32(12):3340-50. PubMed ID: 21296415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of hydrocortisone and BCNU on long-term murine bone marrow cultures.
    Horikoshi A; Murphy MJ
    Chemotherapy; 1985; 31(3):223-7. PubMed ID: 3996090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variations in response of human brain tumors to BCNU in vitro.
    Kornblith PL; Szypko PE
    J Neurosurg; 1978 Apr; 48(4):580-6. PubMed ID: 632883
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of human tumor cell chemosensitivity using the sister chromatid exchange assay.
    Deen DF; Kendall LE; Marton LJ; Tofilon PJ
    Cancer Res; 1986 Apr; 46(4 Pt 1):1599-602. PubMed ID: 3948148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro analysis of BCNU-sensitivity in human malignant gliomas. II. Cross-resistance studies with cisplatinum and nitrosoureas.
    Gerosa MA; Rosenblum ML; Stevanoni G; Licata C; Della Corte V; Marcon C; Bricolo A; Tridente G
    Acta Neurol Scand; 1986 Jan; 73(1):66-70. PubMed ID: 3006422
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the CCNU and BCNU modification of the in vitro radiation response in 9L brain tumor cells of rats.
    Deen DF; Williams ME; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1541-4. PubMed ID: 536259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.